Proehl Investment Ventures LLC 4

4 · Dermata Therapeutics, Inc. · Filed Aug 17, 2021

Form 4

Period: 2021-08-17

10% Owner

Transactions

Conversion
Series 1c Preferred Stock
2021-08-17−25,582,050→ 0 total
→ Common Stock (1,247,904 underlying)
Conversion
Series 1 Preferred Stock
2021-08-17−1,755,622→ 0 total
→ Common Stock (85,640 underlying)
Conversion
Series 1a Warrants
2021-08-17−573,750→ 0 total
From: 2016-11-15Exp: 2026-03-14→ Common Stock (27,987 underlying)
Conversion
Warrant to Purchase Common Stock
2021-08-17+27,987→ 27,987 total
Exercise: $20.50From: 2016-11-15Exp: 2026-03-14→ Common Stock (27,987 underlying)
Conversion
Common Stock
2021-08-17+361,147→ 1,278,464 total
Conversion
Common Stock
2021-08-17+111,951→ 1,390,415 total
Conversion
Common Stock
2021-08-17+181,585→ 1,572,000 total
Conversion
Common Stock
2021-08-17+1,247,904→ 2,819,904 total
Conversion
Common Stock
2021-08-17+85,640→ 2,905,544 total
Conversion
Series 1d Preferred Stock
2021-08-17−2,436,657→ 0 total
→ Common Stock (361,147 underlying)
Conversion
Series 1a Preferred Stock
2021-08-17−2,295,000→ 0 total
→ Common Stock (111,951 underlying)
Conversion
Series 1b Preferred Stock
2021-08-17−3,722,500→ 0 total
→ Common Stock (181,585 underlying)

Footnotes (6)

[F1]The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
[F2]The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
[F3]The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
[F4]The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
[F5]The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
[F6]The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.

Documents

1 file